Scientists at The Scripps Research Institute (TSRI) have revamped to a lifesaving antibiotic called vancomycin, making it capable of eliminating the threat of antibiotic-resistant infections for years to come.
The researchers, led by Dale Boger, co-chair of TSRI’s Department of Chemistry, discover
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Anthonia Obokoh with wired reports
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
